A nurse is reinforcing discharge teaching with client who has stable angina pectoris. Which of the following statements by the client indicates an understanding of what to do when chest pain occurs?

A) Increase in concentration: Chlorpromazine is an antipsychotic medication used to manage symptoms of schizophrenia and other psychotic disorders. While it may have some effects on cognition, an increase in concentration is not the primary therapeutic effect of chlorpromazine.

B) Decrease in delusions: Chlorpromazine is effective in reducing symptoms of psychosis, such as delusions and hallucinations, which are common in conditions like schizophrenia. A decrease in delusions is a direct indicator that the medication is having its intended therapeutic effect.

C) Increase in alertness: Chlorpromazine can cause sedation and drowsiness as side effects, particularly during the initial stages of treatment. An increase in alertness would not be a typical therapeutic outcome, and it may even suggest a side effect like overstimulation or anxiety rather than the intended effect.

D) Decrease in anxiety: While chlorpromazine may have some calming effects, it is primarily used to treat symptoms of psychosis, not anxiety disorders. A decrease in anxiety is not the main therapeutic effect of chlorpromazine. Other medications, such as benzodiazepines, are typically used for anxiety management.

A) Arterial blood gases: Arterial blood gas (ABG) tests are typically used to assess respiratory and metabolic function, including the balance of oxygen and carbon dioxide in the blood. While important in many clinical situations, ABGs are not specifically relevant for monitoring a client on levothyroxine, as it does not directly affect gas exchange or acid-base balance.

B) Thyroid stimulating hormone (TSH): TSH is the most important laboratory test to monitor in a client taking levothyroxine, as this medication is used to replace or supplement thyroid hormone levels. Levothyroxine directly affects thyroid hormone levels in the body, so monitoring TSH levels is essential for determining whether the medication dosage needs to be adjusted. Elevated TSH levels may indicate that the dose is too low, while low levels may suggest an overdose.

C) Prothrombin time: Prothrombin time (PT) is used to assess blood clotting and coagulation status. While certain thyroid conditions can influence coagulation, PT is not a routine test to monitor in clients on levothyroxine therapy unless there are specific concerns related to bleeding or clotting. It is not the most relevant test for monitoring thyroid function in this context.

D) Blood urea nitrogen (BUN): Blood urea nitrogen (BUN) levels reflect kidney function and hydration status. While kidney function is always important to monitor, BUN is not specifically used to assess the effects of levothyroxine therapy. It would not provide direct information regarding the effectiveness of the medication or the thyroid status of the client.